There is much controversy regarding the extent of axon regeneration/sprouting ability in adult human brain. However, intrinsic differences in axon/neurite growth capability amongst striatal (caudate, putamen, nucleus accumbens) subdivisions could conceivably underlie, in part, their differential vulnerability in degenerative human brain disorders. To establish whether the distribution of axon growth markers in mature human striatum might be uniform or heterogeneous, we measured the intra-striatal pattern, in autopsied brain of normal subjects (n = 40, age 18-99), of proteins involved in regulating axon growth. These proteins included polysialylated neural cell adhesion molecule (PSA-NCAM), microtubule-associated proteins TUC-4 (TOAD/ Ulip/CRAMP-4) and doublecortin (DCX), and Bcl-2. The distribution of the marker proteins within the striatum was heterogeneous and inversely related to the pattern of dopamine loss previously characterized in Parkinson's disease (PD), with levels in nucleus accumbens N caudate N putamen, ventral N dorsal, and rostral putamen N caudal. In contrast, distribution of glial markers including glial fibrillary acidic protein (GFAP) and human leukocyte antigens (HLA-DRα and HLA-DR/DQ/DPβ), other Bcl-2 family proteins, and control proteins neuron-specific enolase and α-tubulin in the striatum was either homogeneous or had a pattern unmatched to dopamine loss in PD. The putamen also showed more marked age-dependent decreases in concentrations of PSA-NCAM, TUC-4, and DCX and increases in GFAP levels than caudate. We conclude that the intrastriatal pattern of several key axon growth proteins is heterogeneous in adult human brain. Further investigation will be required to establish whether this pattern, which was inversely correlated with the pattern of dopamine loss in PD, is involved to any extent in the pathophysiology of this degenerative disorder.
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The cardinal feature of Parkinson's disease (PD) is the loss of dopaminergic innervation of the striatum (caudate, putamen, nucleus accumbens; Ehringer and Hornykiewicz, 1960) . Striatal dopamine loss follows a specific pattern in PD (see Fig. 2) , with the putamen, as a whole, losing more dopamine than the caudate, and the nucleus accumbens (NACS) being the least affected. Within caudate/putamen, the dorsal portion is more affected whereas rostrocaudally, posterior putamen lossN anterior and anterior caudate lossN posterior; this pattern is not observed or only less so in other degenerative parkinsonisms including postencephalitic parkinsonism, progressive supranuclear palsy, and multiple system atrophy (MSA) (Bernheimer et al., 1973; Kish et al., 1988; Morrish et al., 1996; Tong et al., 2006b; see Hornykiewicz, 1998 for review) .
Previous efforts to explain sub-regionally specific vulnerability of dopamine neurones in PD have focused largely on nigral cell bodies with little attention paid to the axon terminal region, possibly because of the assumption that pathological changes likely begin in the cell body, rich in concentration of Lewy body, the neuropathological hallmark of PD. Thus, studies of different characteristics amongst dopamine cell bodies such as neuromelanin (Gibb and Lees, 1991; Hirsch et al., 1988; Kastner et al., 1992) , calcium stress (Chan et al., 2007; Damier et al., 1999; Gibb, 1992; Yamada et al., 1990) , the dopamine transporter (Gonzalez-Hernandez et al., 2004; Uhl et al., 1994) , and interactions between calcium, cytosolic dopamine and α-synuclein (Mosharov et al., 2009 ) have disclosed some association between levels of the markers and extent of cell loss, but still of uncertain significance (Obeso et al., 2010) .
